|
EIF4E expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62803104331033E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.39248678832882E-14 |
| Normal-vs-Stage2 |
2.06799999999951E-05 |
| Normal-vs-Stage3 |
5.83979531398882E-11 |
| Normal-vs-Stage4 |
1.83530968200785E-12 |
| Stage1-vs-Stage2 |
1.367770E-01 |
| Stage1-vs-Stage3 |
2.831600E-01 |
| Stage1-vs-Stage4 |
7.923400E-03 |
| Stage2-vs-Stage3 |
6.137500E-02 |
| Stage2-vs-Stage4 |
1.241680E-03 |
| Stage3-vs-Stage4 |
1.041980E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.99680288865056E-15 |
| Normal-vs-AfricanAmerican |
3.72579999996514E-06 |
| Normal-vs-Asian |
1.47439949138573E-10 |
| Caucasian-vs-AfricanAmerican |
9.233800E-01 |
| Caucasian-vs-Asian |
4.363400E-01 |
| AfricanAmerican-vs-Asian |
6.700400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.5989882709091E-13 |
| Normal-vs-Female |
1.6805445923751E-12 |
| Male-vs-Female |
1.692820E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.95463653543493E-12 |
| Normal-vs-Age(41-60Yrs) |
1.00675023873009E-12 |
| Normal-vs-Age(61-80Yrs) |
1.43689504739086E-11 |
| Normal-vs-Age(81-100Yrs) |
2.249400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.352400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.479400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.918800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.564800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.241600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.201200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.707050E-01 |
| Classical-VS-Follicular |
2.065800E-02 |
| Classical-VS-Other |
4.722000E-01 |
| Classical-VS-Normal |
1.63102864547682E-12 |
| Tall-VS-Follicular |
4.597100E-03 |
| Tall-VS-Other |
9.871200E-01 |
| Tall-VS-Normal |
5.4637999680196E-09 |
| Follicular-VS-Other |
1.883800E-01 |
| Follicular-VS-Normal |
2.34439999999836E-05 |
| Other-VS-Normal |
8.787500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.82760037606522E-10 |
| Normal-vs-N1 |
7.88258347483861E-15 |
| N0-vs-N1 |
3.810200E-04 |
|
|
